Gus Cairns Editorial Consultant

Gus joined aidsmap's editorial team in 2009 and previously edited HIV Treatment Update and Preventing HIV. He retired from full-time work in 2023 and now contributes news and conference reports as a freelancer. He is also co-chair for Combination Prevention at the European AIDS Treatment Group.

LinkedIn  |  Facebook

Photo: Steven Doyle

Chemsex & recreational drug use

Chemsex use is changing in Europe

Sexually transmitted infections epidemiology

Increased STI diagnoses in gay men with HIV are mainly due to more testing

Sexually transmitted infections prevention

STIs and doxyPEP at EACS: community effectiveness, gonorrhoea resistance and ‘blunted’ syphilis

The search for a cure

Second Berlin patient has unusual immune response that seems to have removed his HIV

Global health targets

More Europeans are dying from HIV now than 15 years ago

Quality of life

People with HIV report little difference in quality of life compared with matched controls, but more depression

Injectable & long-acting PrEP

Lenacapavir PrEP ‘special cases’: young people, missed doses and drug interactions

Health problems in children & young people

Children born with HIV have persistent inflammation markers linked to heart disease

Finance & funding

The US cuts challenge African funders and governments to provide new models of PrEP access

Finance & funding

Scaling back PEPFAR will leave 700,000 without PrEP and cause 6700 new HIV infections within a year

HIV vaccine & cure research

Engineered T-cells may kill off reservoir cells, mimicking elusive CD8 vaccine effect

Cardiovascular disease

Few people with HIV in England starting statins despite new recommendations

Clinical trials

Phases of clinical trials

PrEP programmes & uptake

Few new HIV cases among Polish PrEP users – most caused by errors with event-based PrEP

Finance & funding

HIV testing requirements must be simplified for injectable PrEP to have a future

Sexually transmitted infections prevention

Why aren’t more people with HIV accessing doxyPEP?

PrEP science

HIV acquisition in women with good adherence to TAF/FTC PrEP is rare

PrEP science

Event-driven PrEP for women may work, modelling study predicts